NIH-funded research R01 grant

Investigating how MDMA can improve mood and social interactions

Official title: MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach

Funded at Mclean Hospital · NIH-11046212 · Data updated 2026-11-12

This study is looking at how MDMA, a drug that can boost mood, might help people with PTSD and depression who haven't found relief from other treatments, while also checking for any risks involved.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMclean Hospital
NIH-funded
Lab location1 site (Belmont, United States)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$766,842
NIH project number1R01MH136052-01A1
Project IDNIH-11046212 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with PTSD or treatment-resistant depression who experience symptoms of anhedonia.

Less likely to help

Patients who do not have PTSD or depression, or those who are not experiencing anhedonia, may not benefit from this research.

What this research studies

This research explores the effects of MDMA, a drug known for its mood-enhancing properties, on conditions like PTSD and depression. By using advanced techniques such as touchscreen assays and electrophysiological recordings in rats, the study aims to understand the neurochemical mechanisms that contribute to the drug's positive effects while also examining its potential risks. The goal is to identify how MDMA can be safely and effectively used as a treatment for patients who have not responded to traditional therapies. This research could lead to new insights into the treatment of anhedonia, a common symptom in various mental health disorders.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for patients suffering from PTSD and depression, particularly those who have not found relief with existing therapies.

How similar studies have gone: Previous research has shown promising results with MDMA in clinical settings, particularly for PTSD, indicating that this approach has potential based on earlier successes.

Where this research is happening

  • Mclean Hospital
    Belmont, United States
    Active

Researchers

  • Principal investigator: Kangas, Brian D. — Mclean Hospital
  • Study coordinator: Kangas, Brian D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.